(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...

A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

The European Union is getting good at adapting to unprecedented circumstances. Over the last five years, the 27 member ...

Influenza has run rampant this winter, but numbers are leveling out, said Dr. Bisola Ojikutu of the city’s Public Health ...

With just one game remaining and the conference tournament looming, Robert Morris Men's Basketball is remaining focused on ...

Officials say the school-aged child was not vaccinated and was hospitalized in Lubbock last week after testing positive for ...

Today, the official Covid death toll in the United States stands at 1.22 million. Excess mortality counts, which compare the ...

Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...